CAN:s bibliotek

*000      am a        a
*00115547
*007cr |||||||||||
*008070120s1999||||xxu||||es|||||||||1|eng||
*020  $a0-16-050141-5
*1001 $aYates, Brian T.
*24510$aMeasuring and improving cost, cost-effectiveness, and cost-benefit for substance abuse treatment programs$ba manual$h[Elektronisk resurs] :
*260  $aBethesda, Md :$bNational Institutes of Health : National Institute on Drug Abuse,$c1999
*300  $a124 s :$bill.
*440  $aNIH publication ;$v99-4518
*500  $aE-bok
*520  $aIntense competition for limited substance abuse program funds, combined with increased scrutiny of program costs and outcomes, has created a need for better understanding of how costs and outcomes are related in substance abuse treatment. Programs are increasingly called on to show that their treatment of substance-abusing patients is a good investment of public and private funds. Program costs must be justified relative to program outcomes (and vice versa). (From the introduction)
*650 4$aSubstance-related disorders
*650 4$aTreatment outcome
*650 4$aEconomics
*650 4$aCosts and cost analysis
*650 4$aCost-benefit analysis
*650 4$aUnited States
*653  $aDrogmissbruk
*653  $aVård
*653  $aBehandling
*653  $aKostnader
*653  $aEkonomi
*653  $aUSA
*7101 $aNational Institutes of Health
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://archive.org/details/measuringimprovi0000yate$zFulltext
^